1. Home
  2. CRGX vs CPF Comparison

CRGX vs CPF Comparison

Compare CRGX & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • CPF
  • Stock Information
  • Founded
  • CRGX 2021
  • CPF 1954
  • Country
  • CRGX United States
  • CPF United States
  • Employees
  • CRGX N/A
  • CPF N/A
  • Industry
  • CRGX
  • CPF Major Banks
  • Sector
  • CRGX
  • CPF Finance
  • Exchange
  • CRGX Nasdaq
  • CPF Nasdaq
  • Market Cap
  • CRGX 621.4M
  • CPF 717.2M
  • IPO Year
  • CRGX 2023
  • CPF N/A
  • Fundamental
  • Price
  • CRGX $12.39
  • CPF $28.51
  • Analyst Decision
  • CRGX Strong Buy
  • CPF Buy
  • Analyst Count
  • CRGX 6
  • CPF 1
  • Target Price
  • CRGX $31.80
  • CPF $30.00
  • AVG Volume (30 Days)
  • CRGX 287.3K
  • CPF 291.4K
  • Earning Date
  • CRGX 11-12-2024
  • CPF 01-29-2025
  • Dividend Yield
  • CRGX N/A
  • CPF 3.65%
  • EPS Growth
  • CRGX N/A
  • CPF N/A
  • EPS
  • CRGX N/A
  • CPF 2.10
  • Revenue
  • CRGX N/A
  • CPF $244,643,000.00
  • Revenue This Year
  • CRGX N/A
  • CPF N/A
  • Revenue Next Year
  • CRGX N/A
  • CPF $7.80
  • P/E Ratio
  • CRGX N/A
  • CPF $13.58
  • Revenue Growth
  • CRGX N/A
  • CPF N/A
  • 52 Week Low
  • CRGX $10.91
  • CPF $18.00
  • 52 Week High
  • CRGX $33.92
  • CPF $33.25
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 39.66
  • CPF 49.00
  • Support Level
  • CRGX $10.91
  • CPF $27.73
  • Resistance Level
  • CRGX $15.75
  • CPF $29.01
  • Average True Range (ATR)
  • CRGX 1.20
  • CPF 0.87
  • MACD
  • CRGX -0.11
  • CPF 0.13
  • Stochastic Oscillator
  • CRGX 30.08
  • CPF 79.18

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.

Share on Social Networks: